Integrative genetics of behavior with high throughput technologies

行为的综合遗传学与高通量技术

• 批准号: 9357186
• 负责人: David Goldman
• 金额: $ 331.91万
• 依托单位: NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/9357186
• 关键词: 4-aminospiroperidol; African; African American; Alcohol dependence; Alcoholism; Alcohols; Alleles; American Indians; Animal Model; Animals; Anterior; Antipsychotic Agents; Anxiety; Autopsy; Behavior; Behavioral; Behavioral Genetics; Brain; Brain imaging; Brain-Derived Neurotrophic Factor; CRH gene; Cell model; Cells; Child; Clinical; Clozapine; Cognition; Cognitive deficits; Collection; Complex; Corpus striatum structure; Craniocerebral Trauma; DISC1 gene; DRD2 gene; Data Set; Diagnosis; Diazepam; Disease; Dopamine; Dorsal; Drosophila genus; Electroencephalography; Emotions; Endocrine; Environmental Risk Factor; Epigenetic Process; Episodic memory; Family; Founder Generation; GTP Cyclohydrolase; Gene Cluster; Genes; Genetic; Genetic Polymorphism; Genetic Variation; Genetic study; Genomic approach; Genomics; Genotype; Glutamates; Goals; Grant; HTR2A gene; Haplotypes; Human; Impulsive Behavior; Impulsivity; Investigation; Knowledge; Ligands; Link; Locomotion; Massive Parallel Sequencing; Mental disorders; Methaqualone; Minisatellite Repeats; Mus; Naltrexone; National Institute of Drug Abuse; Nature; Neurobiology; Neurosciences; Nicotine Dependence; Nonsense-Mediated Decay; Outcome; Pain; Phenotype; Placebo Effect; Population; Poverty; Proteins; RNA; Rattus; Risk; Risk Factors; Rivers; Role; Sampling; Scanning; Schizophrenia; Science; Sexual abuse; Source; Stress; Study models; Substance Addiction; Suicide; Terminator Codon; Testosterone; Translational Research; Validation; Variant; Wistar Rats; Withdrawal; Woman; addiction; alcohol preferring rats; alcohol response; anti social; base; cannabinoid receptor; chronic pain; cognitive function; comparative genomics; craving; deep sequencing; dosage; drug reward; drug withdrawal; exome sequencing; externalizing behavior; fatty acid amide hydrolase; functional genomics; gene discovery; gene interaction; genome wide association study; genome-wide; genome-wide analysis; high risk; high throughput technology; imaging genetics; induced pluripotent stem cell; knockout gene; metabotropic glutamate receptor 2; neuroimaging; neuropeptide Y; novel; pediatric trauma; preference; proband; problem drinker; promoter; receptor expression; response; risk variant; serotonin transporter; trait; transcriptomics; treatment response

Identification of functional variants is an end-game of analysis of genetically influenced diseases and starting point to understand roles of genes in behavioral diseases. Addictions are moderately to highly heritable but most of the genetic variance is unexplained by functional loci or replicated linkages. Using genomic approaches and by focused studies on implicated genes, we have discovered several functional loci with roles in complex behaviors relevant to alcoholism and addictions. These studies make use of founder populations, people at risk because of exposures, and model organisms. We use addiction-relevant intermediate phenotypes that are closer to gene action. Model organisms, including artificially selected mice, rats and fruitflies are used for gene discovery, as well as validation and we use cellular models including iPSC's to bridge between animal models and human. An OPRM1 Asn40Asp missense variant we found (Bergen et al, 1997) was shown by others to be functional and linked to naltrexone treatment response (Anton et al, 2008). A common, functional SNP in the serotonin transporter HTTLPR (Hu et al, 2007) enhanced linkage to OCD,neuroimaging responses to emotion, and gene x stress interactions leading to suicidality (Roy et al, 2007. Common HTR2C Ser23Cys (Lappalainen et al, 1999, Okada et al, 2004) and HTR2A Asn452His variants(Ozaki et al, 1997) were found and shown to be functional, and later linked to behavior, including clozapine response. In first-episode schizophrenics, we found that a functional DRD2 promoter polymorphism influences antipsychotic response (Lencz et al, 2006). We traced linkages of functional loci and haplotypes of NPY (Zhu et al, 2008), GCH1 (Tegeder et al, 2006) and DISC1 (Hodgkinson et al, 2004) to emotionality, schizophrenia and clinical pain outcome. By deep sequencing we found an HTR2B stop codon that is relatively common in Finns, a founder population, absent in others, and associated with but not determinant for impulsive behavior. This stop codon also cosegregated with ASPD and AUD in families and the mouse gene knockout was impulsive and high in novelty seeking and novelty induced locomotion. It leads to variable nonsense mediated decay of the HTR2B RNA and blocked HT2B receptor expression (Bevilacqua et al, Nature, 2010). A low expression Neuropeptide Y (NPY) haplotype increased anxiety and emotionality but had stronger effects on molecules (NPY RNA and protein) and intermediate phenotypes (brain imaging responses to emotion and pain/stress)(Zhou et al, Nature, 2008). Because intermediate phenotypes augment analysis of behavior (Ducci and Goldman)we proposed a multidimensional Addictions Neuroclinical Assessment based on the addiction cycle (Kwako et al, Biol Psych, 2016). The imaging genetics paradigm we helped initiate (Heinz et al, 2000; Hariri et al, 2002; Egan et al, 2001; 2003; Zubieta et al, 2003) led to groundbreaking findings. We found a mechanism of CHRNA5 Asn398, a functional locus altering nicotine addiction risk. The risk allele weakens brain connectivities including a Dorsal Anterior Cingulate/Ventral Striatal circuit predictive of craving (Hong et al, 2010). Clinical subphenotyping enabled linkage of HTR1B to antisocial alcoholism (Lappalainen et al, 1998), serotonin transporter (SLCA4) to anxiety (Mazzanti et al; Hariri et al), BDNF Val66Met to episodic memory (Egan et al, cell, 2003), and GTP cyclohydrolase to chronic pain and experimental pain response (Tegeder et al, 2006). Frontal cognitive deficit is a risk factor in schizophrenia, alcoholism and other diseases. Dopamine generally enhances prefrontal cortical efficiency. Met158, a common COMT variant, leads to four-fold reduction in COMT activity. It is thus a candidate allele for cognitive function via effect on frontal dopamine. We found an allele-dosage relationship of Met158 to frontal cognitive function and diminished cortical efficiency (Egan et al, 2001). The effect on cognition is seen in populations differing in baseline cognitive function: schizophrenia, head injury (Lipsky et al, 2005, 2011), & controls (Malhotra et al, 2002, 2009). We proposed that Val158 has a counter-advantage: stress resiliency. In two populations Met158 predicted anxiety in women and decreased frontal EEG coherence (Enoch et al, 2003), and Met158 was associated with lower resiliency to pain/stress (Zubieta et al, Science, 2003; Diatchenko et al, 2005, 2006. We have extended knowledge of GxE effects of stress related genes such as COMT, NPY, SLC6A4 and SLC6A4 in many studies using both behavioral and endocrine outcomes (Lovallo et al 2015, 2016). A functional polymorphism of Fatty Acid Amide Hydrolase (FAAH) which metabolizes the endogenous ligand for cannabinoid receptors, specifically predicts placebo response to pain (Pecina et al, 2014). GWAS, transcriptomics and exome sequencing are global approaches that enable genomic spaces to be searched independent of prior hypotheses. The Chr 4 GABAA subunit cluster was implicated in alcoholism by family linkage (Long et al, 1998), an effect that appears anxiety-modulated (Enoch et al, 2006). Another GABAA gene cluster implicated in alcoholism and alcohol response is located on Chr 5 (Radel et al, 2005). GABRA6 has a missense variant associated with alcohol dependence and response to alcohol and diazepam (Iwata et al, 2005). A family linkage scan yielded genome-wide significant linkage of CRH-BP to an alcoholism-associated EEG trait and this was supported by association in two populations (Enoch et al, 2008). GWAS of EEG (Hodgkinson et al, PNAS, 2010) in Plains Indians detected three independent genome-wide significant loci(Hodgkinson et al, PNAS 2010). Via GWAS, a schizophrenia risk locus was identified in multiple populations (Lencz et al, Nat Commun, 2013). Founder, phenotypically extreme, and exposed populations enhance power to detect gene effects. Our Finnish dataset, derived from a founder population, was ascertained via criminal alcoholic probands. SW and Plains Indian samples represent founder populations. An African American substance dependence sample with high adversity revealed GxE of childhood trauma and HTTLPR in suicidality (Roy et al, 2007). Stress and poverty, but not African ancestry, predicted high risk of addictions (Ducci et al, 2009). An MAOA VNTR previously linked to dyscontrol via stress interaction was linked to outcomes of alcohol dependence and ASPD in American Indian women, of whom half had been sexually abused as children (Ducci et al, 2008). A strong interaction between a MAOA VNTR and testosterone was observed in the Finnish criminal sample (Sjoberg et al, 2008). As mentioned, deep sequencing in Finns detected a population-specific HTR2B Stop codon significant for impulsivity (Bevilacqua et al, Nature, 2010). We exome-sequenced an artificially selected animal model for alcoholism, the P/NP rat, and discovered a stop codon in the metabotropic glutamate receptor 2 (Grm2) gene that leads to altered glutamate function and increased alcohol preference in alcohol-preferring rats (Zhou et al, 2013). The Grm2 Stop codon is common (0.08) in parental Charles River Wistar rats, and fixed in Wistar from some sources. It leads to uncompensated changes in glutamate function. It was genetically fixed by artificial selection in the alcohol preferring and non-preferring rats illustrating the power of using such strains to discover alleles that alter behavior. Via parallel exome sequencing in selected strains and people we are identifying genes involved in drug reward and withdrawal As facilitated by a NIDA RFA leading to two U01 grants we have identified new loci altering addiction in rat and Drosophila.

功能变异的鉴定是遗传影响疾病分析的终点，也是了解基因在行为疾病中的作用的起点。成瘾是中度到高度遗传的，但大多数遗传变异是通过功能位点或复制联系来解释的。利用基因组方法和对相关基因的重点研究，我们发现了几个与酒精中毒和成瘾相关的复杂行为有关的功能位点。这些研究利用了创始人群、因暴露而处于危险中的人群和模式生物。我们使用成瘾相关的中间表型，更接近基因作用。模式生物，包括人工选择的小鼠、大鼠和果蝇，用于基因发现和验证，我们使用包括iPSC在内的细胞模型在动物模型和人类模型之间架起桥梁。